WP1302

· Worg Biotherapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WP1302, covering 2025-05-08 to 2025-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz [Phase 2]

See pricing